Cargando…

Artificial Intelligence in Current Diabetes Management and Prediction

PURPOSE OF REVIEW: Artificial intelligence (AI) can make advanced inferences based on a large amount of data. The mainstream technologies of the AI boom in 2021 are machine learning (ML) and deep learning, which have made significant progress due to the increase in computational resources accompanie...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Akihiro, Noguchi, Masahiro, Kometani, Mitsuhiro, Furukawa, Kenji, Yoneda, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668843/
https://www.ncbi.nlm.nih.gov/pubmed/34902070
http://dx.doi.org/10.1007/s11892-021-01423-2
_version_ 1784614663681474560
author Nomura, Akihiro
Noguchi, Masahiro
Kometani, Mitsuhiro
Furukawa, Kenji
Yoneda, Takashi
author_facet Nomura, Akihiro
Noguchi, Masahiro
Kometani, Mitsuhiro
Furukawa, Kenji
Yoneda, Takashi
author_sort Nomura, Akihiro
collection PubMed
description PURPOSE OF REVIEW: Artificial intelligence (AI) can make advanced inferences based on a large amount of data. The mainstream technologies of the AI boom in 2021 are machine learning (ML) and deep learning, which have made significant progress due to the increase in computational resources accompanied by the dramatic improvement in computer performance. In this review, we introduce AI/ML-based medical devices and prediction models regarding diabetes. RECENT FINDINGS: In the field of diabetes, several AI-/ML-based medical devices and regarding automatic retinal screening, clinical diagnosis support, and patient self-management tool have already been approved by the US Food and Drug Administration. As for new-onset diabetes prediction using ML methods, its performance is not superior to conventional risk stratification models that use statistical approaches so far. SUMMARY: Despite the current situation, it is expected that the predictive performance of AI will soon be maximized by a large amount of organized data and abundant computational resources, which will contribute to a dramatic improvement in the accuracy of disease prediction models for diabetes.
format Online
Article
Text
id pubmed-8668843
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86688432021-12-28 Artificial Intelligence in Current Diabetes Management and Prediction Nomura, Akihiro Noguchi, Masahiro Kometani, Mitsuhiro Furukawa, Kenji Yoneda, Takashi Curr Diab Rep Diabetes Epidemiology (HC Yeh, Section Editor) PURPOSE OF REVIEW: Artificial intelligence (AI) can make advanced inferences based on a large amount of data. The mainstream technologies of the AI boom in 2021 are machine learning (ML) and deep learning, which have made significant progress due to the increase in computational resources accompanied by the dramatic improvement in computer performance. In this review, we introduce AI/ML-based medical devices and prediction models regarding diabetes. RECENT FINDINGS: In the field of diabetes, several AI-/ML-based medical devices and regarding automatic retinal screening, clinical diagnosis support, and patient self-management tool have already been approved by the US Food and Drug Administration. As for new-onset diabetes prediction using ML methods, its performance is not superior to conventional risk stratification models that use statistical approaches so far. SUMMARY: Despite the current situation, it is expected that the predictive performance of AI will soon be maximized by a large amount of organized data and abundant computational resources, which will contribute to a dramatic improvement in the accuracy of disease prediction models for diabetes. Springer US 2021-12-13 2021 /pmc/articles/PMC8668843/ /pubmed/34902070 http://dx.doi.org/10.1007/s11892-021-01423-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Diabetes Epidemiology (HC Yeh, Section Editor)
Nomura, Akihiro
Noguchi, Masahiro
Kometani, Mitsuhiro
Furukawa, Kenji
Yoneda, Takashi
Artificial Intelligence in Current Diabetes Management and Prediction
title Artificial Intelligence in Current Diabetes Management and Prediction
title_full Artificial Intelligence in Current Diabetes Management and Prediction
title_fullStr Artificial Intelligence in Current Diabetes Management and Prediction
title_full_unstemmed Artificial Intelligence in Current Diabetes Management and Prediction
title_short Artificial Intelligence in Current Diabetes Management and Prediction
title_sort artificial intelligence in current diabetes management and prediction
topic Diabetes Epidemiology (HC Yeh, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668843/
https://www.ncbi.nlm.nih.gov/pubmed/34902070
http://dx.doi.org/10.1007/s11892-021-01423-2
work_keys_str_mv AT nomuraakihiro artificialintelligenceincurrentdiabetesmanagementandprediction
AT noguchimasahiro artificialintelligenceincurrentdiabetesmanagementandprediction
AT kometanimitsuhiro artificialintelligenceincurrentdiabetesmanagementandprediction
AT furukawakenji artificialintelligenceincurrentdiabetesmanagementandprediction
AT yonedatakashi artificialintelligenceincurrentdiabetesmanagementandprediction